Floatz logo

Capecitabine

Metastatic Malignant Neoplasm in the Liver

SWOG Cancer Research NetworkSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

20 Active assets in the Metastatic Malignant Neoplasm in the Liver cohort.

Asset / SponsorPhaseRating
Eloxatin
ECOG-ACRIN Cancer Research Group
Phase 3BB
Oxodotreotide
Vanderbilt-Ingram Cancer Center
Phase 4B
FLUOROURACILUM
ECOG-ACRIN Cancer Research Group
Phase 3B
Calcium folinate pentahydrate
ECOG-ACRIN Cancer Research Group
Phase 3B
Irinotecan
ECOG-ACRIN Cancer Research Group
Phase 3B

View all 29 →

Same molecule, other indications

Capecitabine is also rated in:

Locally Advanced Rectal CancerDormant
BBB
Indicative ·
75 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →
rectal carcinomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →